Перевести на Переведено сервисом «Яндекс.Перевод»

Neovasc Inc.

Link
www.neovasc.com
Country
Canada
Headquarters
13562 Maycrest Way Suite 5138 Richmond British Columbia
Ticker
NASDAQ:NVCN
Description

Neovasc Inc. is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Reducer for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Its Tiara is a product for treating mitral valve disease. The Tiara is in preclinical/early clinical stage development to provide an invasive transcatheter device. The Tiara valve is made up of two components: the leaflets and skirt. It produces Peripatch, a biological tissue product that is manufactured from pericardium, which is the protective sac that surrounds the heart of an animal. It provides product development and specialized manufacturing services related to Peripatch tissue-based products.